Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia

Familial combined hyperlipidemia (FCH), a common cause of premature coronary artery disease, is genetically complex and poorly understood. Recently, a major locus on chromosome 1q21-23 exhibiting highly significant linkage was identified in Finnish FCH families by use of a parametric analysis. We now report highly significant evidence of linkage (maximum LOD score 3.8, recombination fraction 0) of an important FCH phenotype, elevated apolipoprotein B (apoB) levels, to a distinctly separate locus on chromosome 1p31 in Dutch pedigrees. ApoB is the major protein on very low density and low density lipoproteins, and elevated apoB levels have been used as a surrogate trait for FCH. Additional microsatellite markers in the 1p31 region were genotyped, and evidence of linkage improved (maximum LOD score 4.7) in a multipoint analysis of two markers in the peak region. The leptin receptor gene resides within this locus and is involved in obesity and insulin/glucose homeostasis. However, there was no evidence of an association between leptin receptor and apoB levels, raising the possibility that another gene on this chromosomal region contributes to elevated apoB levels in this Dutch population. This is one of the first loci identified for apoB levels in humans and is the second major locus implicated in the genetic etiology of FCH.

[1]  Joseph D. Terwilliger,et al.  Gene Mapping in the 20th and 21st Centuries: Statistical Methods, Data Analysis, and Experimental Design , 2009, Human biology.

[2]  A. Hoeks,et al.  Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[4]  Jonathan C. Cohen,et al.  Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.

[5]  P. Demacker,et al.  Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. , 2000, Atherosclerosis.

[6]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[7]  H. Coon,et al.  Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus: The NHLBI Family Heart Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Attie,et al.  The role of the LDL receptor in apolipoprotein B secretion. , 2000, The Journal of clinical investigation.

[9]  Andreas Busjahn,et al.  Support for linkage of familial combined hyperlipidemia to chromosome 1q21–q23 in Chinese and German families , 2000, Clinical genetics.

[10]  J. Rotter,et al.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. , 1999, American journal of human genetics.

[11]  J D Terwilliger,et al.  Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. , 1999, American journal of human genetics.

[12]  T. Lehtimäki,et al.  Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23 , 1998, Nature Genetics.

[13]  P. McKeigue,et al.  Leptin receptor gene variation and obesity: lack of association in a white British male population. , 1997, Human molecular genetics.

[14]  L. Kiemeney,et al.  Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Rotter,et al.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. , 1997, The Journal of clinical investigation.

[16]  W. Chung,et al.  Genomic structure of the human OB receptor and identification of two novel intronic microsatellites. , 1996, Genome research.

[17]  J. Terwilliger.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. , 1995, American journal of human genetics.

[18]  E. Wijsman,et al.  Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  A A Schäffer,et al.  Avoiding recomputation in linkage analysis. , 1994, Human heredity.

[20]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[21]  P. Cullen,et al.  Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  C. Shoulders,et al.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. , 1993, The Journal of clinical investigation.

[23]  T. D. de Bruin,et al.  Impaired chylomicron remnant clearance in familial combined hyperlipidemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.

[26]  R. Cantor,et al.  Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A , 2000, International Journal of Obesity.

[27]  A. J. Lusis,et al.  Novel genes for familial combined hyperlipidemia. , 1999, Current opinion in lipidology.

[28]  J. Rotter,et al.  Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. , 1996, Journal of lipid research.

[29]  T. Beaty,et al.  Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia , 1993, Genetic epidemiology.